Baas Research & Development has been acquired by VoestAlpine AG
Baas B.V., a subsidiary of TBI Holding B.V., has successfully sold its research and development division Baas R&D to VoestAlpine A.G. for an undisclosed consideration.
Baas R&D is an independently operating research, development and consultancy division, specialized in innovative practical applications in optoelectronics and optical fiber technology. Baas R&D has developed and manufactured various applications for the railway environment, which have been successfully implemented in several countries both within and outside Europe. Tiemen Schra, CEO of Baas B.V., expects continued growth and an even stronger market position for the company in the future: “Baas R&D has a very good strategic fit with VoestAlpine. VoestAlpine will enable the company to capitalize on its unique know-how and to further develop and broaden its product range as well as expand its position to new geographical markets.”
VoestAlpine is an international steel company and the largest railway producer in Europe. Through its subsidiary SST Signal & Technik GmbH, VoestAlpine also has a strong focus on the market for railway infrastructure monitoring. Thomas Starzer, Senior Vice President Internationalization of VoestAlpine, commented: “From the moment we were approach by the Dutch team, I was convinced that the products and know-how of Baas R&D were a strong addition to our current portfolio. The team had a professional approached throughout the acquisition process.”
Baas B.V. is a technical service provider focused on infrastructure, data and telecommunications networks as well as technical installations. It is a subsidiary of TBI Holding B.V. TBI is the third largest technical service provider and fourth largest building company in the Netherlands.
Oaklins' small cap advisory team in the Netherlands acted as M&A advisor to the seller in this transaction.
Talk to the deal team
Related deals
Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more